Here are five companies leading the personalized genomics industry, based on MIT Technology Review‘s 50 Smartest Companies 2017 list.
1. Mountain View, Calif.-based 23andMe, a direct-to-consumer health and ancestry DNA-testing service
2. San Diego-based Illumina, which creates sequencing and array-based technologies to advance life science research
3. Oxford (U.K.) Nanopore, the makers of a handheld sequencer for on-the-go DNA decoding
4. Saint Sulpice, Switzerland-based Sophia Genetics, an analytics platform for clinical genomics
5. Danvers, Mass.-based Veritas Genetics, which develops and offers whole-genome sequencing
More articles on health IT:
March on Google called off following ‘credible threats’
Sutherland Healthcare selects Dr. Shailja Dixit as CMO: 3 points
Fundraiser supporting legal defense of cyber researcher pulled, donations from stolen credit cards
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
